foscarnet has been researched along with Hyperamylasemia in 1 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
Hyperamylasemia: A condition with abnormally elevated level of AMYLASES in the serum. Hyperamylasemia due to PANCREATITIS or other causes may be differentiated by identifying the amylase isoenzymes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 31-year-old man with acute myelogenous leukemia underwent CBT." | 1.33 | Pancreatic hyperamylasemia and hyperlipasemia in association with cytomegalovirus infection following unrelated cord blood transplantation for acute myelogenous leukemia. ( Asano, S; Iseki, T; Konuma, T; Ooi, J; Takahashi, S; Takasugi, K; Tojo, A; Tomonari, A; Tsukada, N, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tomonari, A | 1 |
| Takahashi, S | 1 |
| Takasugi, K | 1 |
| Ooi, J | 1 |
| Tsukada, N | 1 |
| Konuma, T | 1 |
| Iseki, T | 1 |
| Tojo, A | 1 |
| Asano, S | 1 |
1 other study available for foscarnet and Hyperamylasemia
| Article | Year |
|---|---|
Pancreatic hyperamylasemia and hyperlipasemia in association with cytomegalovirus infection following unrelated cord blood transplantation for acute myelogenous leukemia.
Topics: Adult; Amylases; Antiviral Agents; Cord Blood Stem Cell Transplantation; Cytomegalovirus Infections; | 2006 |